Xiaoling Kuai

Dr. Xiaoling Kuai


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Human Pathology
Verified
Journal Article
Closed access
CJChunyi Jiang
Chunyi Jiang
YZYi Zhou
Yi Zhou
YHYiyang Huang
Yiyang Huang
YWYan Wang
Yan Wang
WWWei Wang
Wei Wang
XKXiaoling Kuai
Xiaoling Kuai

3 June 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
BLBing Lu
Bing Lu
JSJiawen Shi
Jiawen Shi
TCTong Cheng
Tong Cheng
CWCongshuo Wang
Congshuo Wang
MXManyu Xu
Manyu Xu
XKXiaoling Kuai
Xiaoling Kuai
Objective: Gastric cancer (GC) is the world’s third-leading cause of cancer-related mortality; the prognosis for GC patients remains poor in terms of a lack of reliable biomarkers for early diagnosis and immune therapy response prediction. Here, we aim to discover the connection between chemokine ligand 14 (CCL14) expression in the gastric tumor microenvironment (TME) and its clinical significance and investigate its correlation with immune cell infiltration.Methods: We assessed CCL14 mRNA expression and its interrelation with tumor-infiltrating immune cells (TILs) using bioinformatics analysis in gastric cancer. CCL14 protein expression, TILs, and immune checkpoints were detected by multiple immunohistochemistry analyses in gastric cancer tissue microarrays. Then, we conducted statistics analysis to determine the association between CCL14-related patient survival and immune cell infiltration (p < 0.05).Results: We found that the CCL14 protein was separately expressed in the carcinoma cells and TILs in stomach cancer tissues. The CCL14 protein was related to tumor differentiation and tumor depth and positively correlated with the presentation of LAG3 and PD-L1 in gastric cancer cells. In addition, the CCL14 protein in the TILs of gastric cancer tissues was related to Lauren’s type cells, T cells (CD4+ and CD8+), and CD68+ macrophages in the TME. Kaplan–Meier survival and multivariate analyses showed that the CCL14 expression in gastric cancer cells was an independent prognostic factor.Conclusion: Our study illustrated that CCL14 is a poor prognosis biomarker in gastric cancer, which may be associated with the potential for immunotherapy.